Pfizer PFE stock has been reeling under the pressure of a declining top line due to a steep drop in revenues from its ...

Shares of Pfizer Inc. PFE advanced 1.26% to $28.05 Friday, on what proved to be an all-around great trading session for the ...

Pfizer on Monday urged a U.S. appeals court not to revisit its decision to bar an anti-affirmative action group's challenge ...

Pfizer Inc. expects to inform employees of a “transition plan” at a facility in Sanford, the company said Wednesday, weeks ...

Pfizer's valuation looks attractive, but that doesn't mean the stock is a lock to outperform the broader market.

Novartis, Pfizer, Novo Nordisk, and Otsuka Pharmaceutical were scolded by a U.K. industry group for violating a voluntary ...

Pfizer and Moderna's legal battle over their rival COVID-19 vaccines looks set to continue after London's High Court gave a ...

Will local startups give big pharma its next blockbuster drug? Eli Lilly and Pfizer are launching new biotech incubators in.

The findings add to research showing vaccination during pregnancy is safe and effective amid growing evidence of severe risks ...

Pfizer is certainly not a high-growth business, but has a high dividend yield and cheap stock price. Learn why PFE stock is a ...

Pfizer has hired a new oncology commercialization leader to help the business reach its goal of marketing eight blockbuster ...

Pfizer shares have suffered a painful slide as pandemic revenue dried up. But management is committed to maintaining and ...